PACTR201602001355272招募中2 期
Convalescent Plasma for Early Ebola Virus Disease in Sierra Leone
niversity of Liverpool0 个研究点目标入组 130 人开始时间: 2015年11月20日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 130
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 Year(s) 至 0 Year(s)（—）
- 性别
- Male
入选标准
- •- Pregnant
- •- PCR-¿confirmed,
- •symptomatic
- •participate
- •regulations):
排除标准
- •investigator
- •450-¿500ml
- •detrimental
- •decompensated
- •Unresponsive
- •Responsive,
- •Responsive,
- •Unresponsive)
- •intervention
- •presentation
- •haemorrhage
研究者
相似试验
已完成
2 期
Convalescent plasma for early Ebola virus disease in Sierra LeoneEarly Ebola virus diseaseInfections and InfestationsISRCTN13990511niversity of Liverpool230
已完成
3 期
Convalescent plasma from cured coronavirus disease (COVID) patients as a therapy for patients with severe COVID disease (CONCOVID)CoronavirusCOVID-19SARS-CoV-210047438NL-OMON50016Erasmus MC, Universitair Medisch Centrum Rotterdam87
招募中
不适用
Effect of convalescent plasma in patients with severe COVI-19C01.925.782.600.550.200C01.757Coronavirus infectionSepsisRBR-4vm3yyInstituto Estadual de Hematologia Arthur Siqueira Cavalcanti
招募中
不适用
se of Convalescent Plasma in the treatment of COVID-19IRCT20200414047072N1Hilton Pharma Pvt. Ltd.357
招募中
3 期
Convalescent Plasma Therapy from Recovered Patients to Treat COVID-19 Early in SARS-CoV-2 DiseaseNL-OMON49795Erasmus MC, Universitair Medisch Centrum Rotterdam690